Japan has contracted to supply about 144 million doses of the Pfizer-BioNTech vaccine this year and will request to have most of it delivered by June, the country's health minister, Norihisa Tamura, said. Pfizer is so far the only company that has applied for emergency vaccine approval in Japan, but the country also has contracts with Moderna, AstraZeneca and Novavax.